The Early Treatment of the Delta Variant - COVID19
Drs Cole, Chetty, Kory & Urso
Four distinguished medical doctors, not only highly knowledgeable with the treatment of COVID-19, but also with direct experience in treating patients with the Delta, participated in the event: Dr Ryan Cole from Idaho, USA, Dr Shankara Chetty from South Africa, Dr Pierre Kory, from NY, USA, and Dr Richard Urso from Texas, USA.
The Delta, which represents the vast majority of new cases in the US and many other countries, requires indeed a slightly different approach for its early treatment.
There are four videos with the presentations/remarks of each speaker. There will also be a video with excerpts of the Q&As as well as podcast episode(s).
0:13 / 16:22
- Dr. Chetty’s Approach toTreating for the Delta Variant
- Dr. Pierre Kory Discusses the Revision of the FLCCC Treatment Protocols
- Dr. Richard Urso Comments on the Delta Variant and the Need to Constantly Adapt Protocols
Dr. Ryan Cole is a board-certified dermatopathologist (AP & CP) and the CEO/Medical Director of Cole Diagnostics. He has worked as an independent pathologist since 2004. Some highlights from his CV: Ackerman Academy of Dermatopathology (July 2002-June 2003): Dermatopathology Fellowship (Chief Fellow). Mayo Clinic (July 1997-June 2002): Resident in Anatomic and Clinical Pathology. Chief Fellow, Surgical Pathology Fellowship. Medical College of Virginia (1993-1997): Researched immunology. Served as President of Student Family Practice organization. Coordinated activities and seminars on the practice of family medicine and rural medicine. Earned MD in 1997.
Dr. Shankara Chetty is a Family General Medical Practitioner in South-Africa. Dr Chetty has a considerable experience with the outpatient treatment of COVID-19, having treated so far some 4,000 patients. He holds a degree in medicine and surgery and also has advanced education in genetics, advanced biology, biochemistry and microbiology. About his 8th Day Therapy, check our article and this related article.
Dr. Pierre Kory is Board Certified in Internal Medicine, Critical Care, and Pulmonary Medicine. He is the former Chief of the Critical Care Service and former Associate Professor at the University of Wisconsin. Prior to this, he served as the Program Director of a Pulmonary and Critical Care Fellowship Training Program at Mount Sinai Beth Israel in New York City. Dr. Kory is considered a pioneer and national/international expert in critical care ultrasound and is the senior editor of a best-selling textbook on the subject which is in its 2nd edition and has been translated into 7 languages and has won the Presidents Choice Award from the British Medical Association in 2015. Dr. Kory is also considered a master educator and has won multiple major Departmental Teaching Awards at each institution that I have served as Faculty. In the COVID pandemic, Dr. Kory has travelled across multiple states in the US to care for COVID-19 patients and is also the President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance.
Dr. Richard Urso is a medical doctor and scientist who invented an FDA approved wound healing drug. With a background in drug development, he has been advocate for early treatment since March 2020. He’s appeared on over 60 media outlets including Laura Ingraham, Charlie Kirk, and C span. He’s met with leaders of the Covid task force such as Vice President Pence, Deborah Birx, leaders of the Congress, Senate and CDC. He’s played a prominent role in Covid awareness in Texas, meeting with members of the Governor’s office and testifying before the Texas Senate.